Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
Title | Myasthenia gravis genome-wide association study implicates AGRN as a risk locus. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Topaloudi, A., Zagoriti Z., Flint A. Camille, Martinez M. Belle, Yang Z., Tsetsos F., Christou Y-P., Lagoumintzis G., Yannaki E., Zamba-Papanicolaou E., Tzartos J., Tsekmekidou X., Kotsa K., Maltezos E., Papanas N., Papazoglou D., Passadakis P., Roumeliotis A., Roumeliotis S., Theodoridis M., Thodis E., Panagoutsos S., Yovos J., Stamatoyannopoulos J., Poulas K., Kleopa K., Tzartos S., Georgitsi M., & Paschou P. |
Journal | J Med Genet |
Date Published | 2021 Aug 16 |
ISSN | 1468-6244 |
Abstract | BACKGROUND: Myasthenia gravis (MG) is a rare autoimmune disorder affecting the neuromuscular junction (NMJ). Here, we investigate the genetic architecture of MG via a genome-wide association study (GWAS) of the largest MG data set analysed to date. |
DOI | 10.1136/jmedgenet-2021-107953 |
Alternate Journal | J Med Genet |
PubMed ID | 34400559 |